Stay updated on Pediatric Ph+ CML Clinical Trial.
Sign up to get notified when there's something new on the Pediatric Ph+ CML Clinical Trial. page.

Latest updates to the Pediatric Ph+ CML Clinical Trial. page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe ClinicalTrials.gov record for the pediatric nilotinib study is displayed, including its study design, outcomes, locations, and results information, in place of a 403 error page.SummaryDifference91%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the page’s 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedA 403 Forbidden message appears in the study record area, with a Home link, rather than study information.SummaryDifference0.5%

Stay in the know with updates to Pediatric Ph+ CML Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Pediatric Ph+ CML Clinical Trial. page.